Literature DB >> 3493947

Epidermal growth factor from deer (Cervus elaphus) submaxillary gland and velvet antler.

K M Ko, T T Yip, S W Tsao, Y C Kong, P Fennessy, M C Belew, J Porath.   

Abstract

Epidermal growth factor (EGF)-like activity was isolated for the first time from the submaxillary gland (SMG) and the velvet antler of red deer (Cervus elaphus) by a combination of Sephadex gel or DEAE-Sephacel and IMAC columns in succession. The semipurified cervine EGF-like activity (cEGF), with specific activity of 4.7 ng/micrograms protein from the velvet tissues, can generate a completely parallel competitive binding curve against mouse EGF in both radioreceptor assay (RRA) and radioimmunoassay (RIA). Mitogenic activity of EGF from both tissues was demonstrated by stimulating the incorporation of [3H]thymidine in two different cell lines of fibroblast culture in a dose-dependent manner. The velvet layer may be the site of EGF synthesis outside the SMG.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493947     DOI: 10.1016/0016-6480(86)90143-7

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  3 in total

1.  The Antiinfective Effects of Velvet Antler of Formosan Sambar Deer (Cervus unicolor swinhoei) on Staphylococcus aureus-Infected Mice.

Authors:  Ting-Yeu Dai; Chih-Hua Wang; Kun-Nan Chen; I-Nung Huang; Wei-Sheng Hong; Sheng-Yao Wang; Yen-Po Chen; Ching-Yun Kuo; Ming-Ju Chen
Journal:  Evid Based Complement Alternat Med       Date:  2011-04-07       Impact factor: 2.629

2.  Dietary supplementation of female rats with elk velvet antler improves physical and neurological development of offspring.

Authors:  Jiongran Chen; Murray R Woodbury; Jane Alcorn; Ali Honaramooz
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-03       Impact factor: 2.629

3.  Deer Antler Extract Improves Fatigue Effect through Altering the Expression of Genes Related to Muscle Strength in Skeletal Muscle of Mice.

Authors:  Jaw-Chyun Chen; Chien-Yun Hsiang; Yung-Chang Lin; Tin-Yun Ho
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-20       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.